APA |
Üçüncü Kefeli, A., Atasoy, B. M., Özgen, Z., Sarı, M., et al. (2014). Recurrence of nasopharyngeal carcinoma in the mastoid region: Therapeutic approach of a rare clinical entity. Marmara Medical Journal, 27(2), 129-131. |
|
AMA |
Üçüncü Kefeli A, Atasoy BM, Özgen Z, Sarı M, Dede F, Dane F. Recurrence of nasopharyngeal carcinoma in the mastoid region: Therapeutic approach of a rare clinical entity. Marmara Med J. May 2014;27(2):129-131. |
|
Chicago |
Üçüncü Kefeli, Ayşegül, Beste Melek Atasoy, Zerrin Özgen, Murat Sarı, Fuat Dede, and Faysal Dane. “Recurrence of Nasopharyngeal Carcinoma in the Mastoid Region: Therapeutic Approach of a Rare Clinical Entity”. Marmara Medical Journal 27, no. 2 (May 2014): 129-31. |
|
EndNote |
Üçüncü Kefeli A, Atasoy BM, Özgen Z, Sarı M, Dede F, Dane F (May 1, 2014) Recurrence of nasopharyngeal carcinoma in the mastoid region: Therapeutic approach of a rare clinical entity. Marmara Medical Journal 27 2 129–131. |
|
IEEE |
A. Üçüncü Kefeli, B. M. Atasoy, Z. Özgen, M. Sarı, F. Dede, and F. Dane, “Recurrence of nasopharyngeal carcinoma in the mastoid region: Therapeutic approach of a rare clinical entity”, Marmara Med J, vol. 27, no. 2, pp. 129–131, 2014. |
|
ISNAD |
Üçüncü Kefeli, Ayşegül et al. “Recurrence of Nasopharyngeal Carcinoma in the Mastoid Region: Therapeutic Approach of a Rare Clinical Entity”. Marmara Medical Journal 27/2 (May 2014), 129-131. |
|
JAMA |
Üçüncü Kefeli A, Atasoy BM, Özgen Z, Sarı M, Dede F, Dane F. Recurrence of nasopharyngeal carcinoma in the mastoid region: Therapeutic approach of a rare clinical entity. Marmara Med J. 2014;27:129–131. |
|
MLA |
Üçüncü Kefeli, Ayşegül et al. “Recurrence of Nasopharyngeal Carcinoma in the Mastoid Region: Therapeutic Approach of a Rare Clinical Entity”. Marmara Medical Journal, vol. 27, no. 2, 2014, pp. 129-31. |
|
Vancouver |
Üçüncü Kefeli A, Atasoy BM, Özgen Z, Sarı M, Dede F, Dane F. Recurrence of nasopharyngeal carcinoma in the mastoid region: Therapeutic approach of a rare clinical entity. Marmara Med J. 2014;27(2):129-31. |
|